AN IN-SILICO STUDY OF ANDALIMAN (Zanthoxylum acanthopodium DC.) AS AN ANTICANCER AGENT AGAINST TYROSINE KINASE ENZYME INHIBITION USING THE DOCKING METHOD: IN SILICO MOLECULAR DOCKING STUDY OF ACTIVE COMPOUNDS FROM ANDALIMAN (Zanthoxylum acanthopodium DC.) AGAINST TYROSINE KINASE ENZYME AS AN ANTICANCER AGENT. fj. 2026;6(1):348-372. doi:10.51771/fj.v6i1.2155